<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR59" class="ref">
 <label class="label">59.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Carpenter</surname>
    <given-names class="given-names">JF</given-names>
   </name>
   <name class="name">
    <surname class="surname">Randolph</surname>
    <given-names class="given-names">TW</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jiskoot</surname>
    <given-names class="given-names">W</given-names>
   </name>
   <name class="name">
    <surname class="surname">Crommelin</surname>
    <given-names class="given-names">DJ</given-names>
   </name>
   <name class="name">
    <surname class="surname">Middaugh</surname>
    <given-names class="given-names">CR</given-names>
   </name>
   <name class="name">
    <surname class="surname">Winter</surname>
    <given-names class="given-names">G</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality</article-title>
  <source class="source">J Pharm Sci</source>
  <year class="year">2009</year>
  <volume class="volume">98</volume>
  <issue class="issue">4</issue>
  <fpage class="fpage">1201</fpage>
  <lpage class="lpage">1205</lpage>
  <?supplied-pmid 18704929?>
  <pub-id pub-id-type="pmid" class="pub-id">18704929</pub-id>
 </element-citation>
</ref>
